Consolidated Financial Results
for the Fiscal Year Ended December 31, 2021
[Japanese GAAP]
February 7, 2022
Company name: GMO Pepabo, Inc.
Stock exchange listing: Tokyo Stock Exchange
Code number: 3633
URL: https://pepabo.com/
Representative: Kentaro Sato, CEO and President
Contact: Yoshito Igashima, CFO and Board Director
Phone: +81-3-5456-3021
Scheduled date of Annual General Meeting of Shareholders: March 19, 2022
Scheduled date of commencing dividend payments: March 22, 2022
Scheduled date of filing annual securities report: March 22, 2022
Availability of supplementary briefing material on annual financial results: Available
Schedule of annual financial results briefing session: Scheduled (for institutional investors and analysts)
(Amounts of less than one million yen are rounded down.)
1. Consolidated Financial Results for the Fiscal Year Ended December 31, 2021 (from January 1, 2021 to December 31, 2021)
(1) Consolidated Operating Results | (% indicates changes from the previous corresponding period.) | |||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | |||||
owners of parent | ||||||||
Fiscal year ended | Million yen | % | Million yen | % | Million yen | % | Million yen | % |
December 31, 2021 | 11,879 | 7.9 | 888 | (4.2) | 968 | (1.6) | 715 | (13.8) |
December 31, 2020 | 11,014 | 23.2 | 927 | 18.3 | 983 | 17.7 | 829 | 52.9 |
(Note) Comprehensive income: Fiscal year ended December 31, 2021: ¥781 million [(9.1)%] Fiscal year ended December 31, 2020: ¥860 million [73.5%]
Basic earnings | Diluted earnings | Rate of return on | Ordinary profit | Operating profit | |
per share | per share | equity | to total assets | to net sales | |
Fiscal year ended | Yen | Yen | % | % | % |
December 31, 2021 | 135.22 | 134.47 | 26.2 | 11.3 | 7.5 |
December 31, 2020 | 159.07 | 157.86 | 39.2 | 13.5 | 8.4 |
(Reference) Equity in earnings (losses) of affiliated companies: Fiscal year ended December 31, 2021: ¥0 million Fiscal year ended December 31, 2020: ¥4 million
(2) Consolidated Financial Position
Total assets | Net assets | Equity ratio | Net assets per share | |||||||
Million yen | Million yen | % | Yen | |||||||
As of December 31, 2021 | 8,870 | 2,953 | 32.9 | 549.33 | ||||||
As of December 31, 2020 | 8,211 | 2,544 | 30.6 | 476.66 | ||||||
(Reference) Equity: As of December 31, 2021: ¥2,938 million | ||||||||||
As of December 31, 2020: ¥2,515 million | ||||||||||
(3) Consolidated Cash Flows | ||||||||||
Cash flows from | Cash flows from | Cash flows from | Cash and | |||||||
cash equivalents | ||||||||||
operating activities | investing activities | financing activities | ||||||||
at end of period | ||||||||||
Fiscal year ended | Million yen | Million yen | Million yen | Million yen | ||||||
December 31, 2021 | 669 | (278) | (392) | 3,620 | ||||||
December 31, 2020 | 1,253 | (5) | (78) | 3,622 | ||||||
1 |
2. Dividends
Annual dividends | Total | Payout | Dividends | |||||
dividends | ratio | to net assets | ||||||
1st | 2nd | 3rd | Year-end | Total | ||||
quarter-end | quarter-end | quarter-end | (annual) | (consolidated) | (consolidated) | |||
Fiscal year ended | Yen | Yen | Yen | Yen | Yen | Million yen | % | % |
December 31, 2020 | 0.00 | 0.00 | 0.00 | 81.00 | 81.00 | 427 | 50.9 | 20.1 |
December 31, 2021 | 0.00 | 0.00 | 0.00 | 68.00 | 68.00 | 360 | 50.3 | 13.3 |
Fiscal year ending | ||||||||
December 31, 2022 | 0.00 | 0.00 | 0.00 | 74.00 | 74.00 | 50.0 | ||
(Forecast) |
3. Consolidated Financial Results Forecast for the Fiscal Year Ending December 31, 2022 (from January 1, 2022 to December 31, 2022)
(% indicates changes from the previous corresponding period.)
Net sales | Operating profit | Ordinary profit | Profit attributable to | Basic earnings | |||||
owners of parent | per share | ||||||||
First half | Million yen | % | Million yen | % | Million yen | % | Million yen | % | Yen |
- | - | - | - | - | - | - | - | - | |
(cumulative) | |||||||||
Full year | 11,482 | (3.3) | 1,143 | 28.7 | 1,156 | 19.5 | 785 | 9.7 | 147.92 |
(Note) Figures of the forecast for the first half (cumulative) of the fiscal year ending December 31, 2022 are not prepared.
(Note) The Company plans to adopt the Accounting Standard for Revenue Recognition, etc. (hereinafter "Revenue Recognition Standard") from the beginning of the first quarter of the fiscal year ending December 31, 2022. Accordingly, the forecasts are based on the application of the said standard, etc. In accordance with the previous standard, for the fiscal year ending December 31, 2022, Net sales were 13,674 million yen (up 15.1% year-on-year), Operating profit 1,135 million yen (up 27.7% year-on-year), Ordinary profit 1,148 million yen (up 18.6% year-on-year) and Profit attributable to owners of parent 779 million yen (up 8.9% year-on-year).
* Notes:
-
Changes in significant subsidiaries during the fiscal year ended December 31, 2021: No (Changes in specified subsidiaries resulting in changes in scope of consolidation)
New: None
Excluded: None - Changes in accounting policies, changes in accounting estimates and retrospective restatement
- Changes in accounting policies due to the revision of accounting standards: No
- Changes in accounting policies other than 1) above: No
- Changes in accounting estimates: No
- Retrospective restatement: No
- Total number of issued shares (common shares)
-
Total number of issued shares at the end of the period (including treasury stock): December 31, 2021: 5,468,700 shares
December 31, 2020: 5,468,700 shares - Total number of treasury stock at the end of the period:
-
Total number of issued shares at the end of the period (including treasury stock): December 31, 2021: 5,468,700 shares
December 31, 2021: 161,721 shares
December 31, 2020: 191,288 shares
3) Average number of shares during the period:
Fiscal year ended December 31, 2021: 5,290,765 shares
Fiscal year ended December 31, 2020: 5,217,364 shares
2
- These financial results are outside the scope of audit by certified public accountants or audit firms
- Explanation of the proper use of financial results forecast and other notes
The statements concerning future performance presented in this document are based on currently available information and certain preconditions which the Company believes to be reasonable at this time and does not constitute a guarantee of the Company to achieve. Actual results may be substantially different from these forecasts presented herein due to various factors.
3
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GMO Pepabo Inc. published this content on 07 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 07 February 2022 06:37:01 UTC.